clinical trial · NCT00521690
The Effect of Insulin Detemir on Blood Glucose Control in Taiwanese Patients With Type 2 Diabetes Failing on OAD
Novo Nordisk A/S·phase4·completed·n = 25
DiabetesDiabetes Mellitus, Type 2insulin detemir
brief summary
The trial is conducted in Asia. The aim of the trial is to evaluate the effect of insulin detemir on blood glucose control in Taiwanese patients with type 2 diabetes failing on OAD with/without once-daily NPH Insulin treatment.
started
Dec 1, 2006
primary completion
Aug 1, 2007
completion
Aug 1, 2007
last updated
Nov 2, 2023
official title
Safety and Therapeutic Effect of Insulin Detemir in Taiwanese Patients With Type 2 Diabetes Mellitus Not Achieving Glycaemic Targets With OAD With/Without Once-daily NPH Insulin Treatment
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol